Diamyd Medical Ab
Clinical trials sponsored by Diamyd Medical Ab, explained in plain language.
-
New shot aims to save Insulin-Making cells in type 1 diabetes
Disease control OngoingThis study tests an experimental treatment called Diamyd (retogatein) in 321 adolescents and adults recently diagnosed with type 1 diabetes who have a specific genetic marker (HLA DR3-DQ2). The goal is to see if three injections into a lymph node, along with vitamin D, can help p…
Phase: PHASE3 • Sponsor: Diamyd Medical AB • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
Could a simple injection stop type 1 diabetes before it starts?
Prevention OngoingThis study tests a treatment called Diamyd® in children aged 8 to 17 who are at high risk for type 1 diabetes. The goal is to see if giving the drug directly into lymph nodes is safe and can prevent or delay the disease. Only 5 children with specific genetic markers are taking pa…
Phase: PHASE2 • Sponsor: Diamyd Medical AB • Aim: Prevention
Last updated May 26, 2026 10:15 UTC